Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 400

1.

Assessment of the quality and content of website health information about herbal remedies for menopausal symptoms.

Sowter J, Astin F, Dye L, Marshall P, Knapp P.

Maturitas. 2016 Jun;88:16-22. doi: 10.1016/j.maturitas.2016.02.016. Epub 2016 Mar 4.

PMID:
27105691
2.

Crumpled Graphene Photodetector with Enhanced, Strain-Tunable, and Wavelength-Selective Photoresponsivity.

Kang P, Wang MC, Knapp PM, Nam S.

Adv Mater. 2016 Apr 6. doi: 10.1002/adma.201600482. [Epub ahead of print]

PMID:
27061899
3.

Expression of the energy substrate transporters in uterine fibroids.

Knapp P, Chabowski A, Posmyk R, Górski J.

Prostaglandins Other Lipid Mediat. 2016 Feb 27;123:9-15. doi: 10.1016/j.prostaglandins.2016.02.002. [Epub ahead of print]

PMID:
26932421
4.

Central HIV-1 Tat exposure elevates anxiety and fear conditioned responses of male mice concurrent with altered mu-opioid receptor-mediated G-protein activation and β-arrestin 2 activity in the forebrain.

Hahn YK, Paris JJ, Lichtman AH, Hauser KF, Sim-Selley LJ, Selley DE, Knapp PE.

Neurobiol Dis. 2016 Feb 1. pii: S0969-9961(16)30012-2. doi: 10.1016/j.nbd.2016.01.014. [Epub ahead of print]

PMID:
26845176
5.

5α-reduced progestogens ameliorate mood-related behavioral pathology, neurotoxicity, and microgliosis associated with exposure to HIV-1 Tat.

Paris JJ, Zou S, Hahn YK, Knapp PE, Hauser KF.

Brain Behav Immun. 2016 Jan 13. pii: S0889-1591(16)30007-1. doi: 10.1016/j.bbi.2016.01.007. [Epub ahead of print]

PMID:
26774528
6.

Functional Characterization and Drug Response of Freshly Established Patient-Derived Tumor Models with CpG Island Methylator Phenotype.

Maletzki C, Huehns M, Knapp P, Waukosin N, Klar E, Prall F, Linnebacher M.

PLoS One. 2015 Nov 30;10(11):e0143194. doi: 10.1371/journal.pone.0143194. eCollection 2015.

7.

HIV-1 Tat regulates the expression of the dcw operon and stimulates the proliferation of bacteria.

Wei J, Zhang Y, Knapp PE, Zhao T.

Microb Pathog. 2016 Jan;90:34-40. doi: 10.1016/j.micpath.2015.11.005. Epub 2015 Nov 17.

PMID:
26596708
8.

Diabetes Screening Among Underserved Adults With Severe Mental Illness Who Take Antipsychotic Medications.

Mangurian C, Newcomer JW, Vittinghoff E, Creasman JM, Knapp P, Fuentes-Afflick E, Schillinger D.

JAMA Intern Med. 2015 Dec;175(12):1977-9. doi: 10.1001/jamainternmed.2015.6098. No abstract available.

PMID:
26551047
9.

Morphine Tolerance and Physical Dependence Are Altered in Conditional HIV-1 Tat Transgenic Mice.

Fitting S, Stevens DL, Khan FA, Scoggins KL, Enga RM, Beardsley PM, Knapp PE, Dewey WL, Hauser KF.

J Pharmacol Exp Ther. 2016 Jan;356(1):96-105. doi: 10.1124/jpet.115.226407. Epub 2015 Nov 5.

PMID:
26542403
10.

HIV-1-Tat Protein Inhibits SC35-mediated Tau Exon 10 Inclusion through Up-regulation of DYRK1A Kinase.

Kadri F, Pacifici M, Wilk A, Parker-Struckhoff A, Del Valle L, Hauser KF, Knapp PE, Parsons C, Jeansonne D, Lassak A, Peruzzi F.

J Biol Chem. 2015 Dec 25;290(52):30931-46. doi: 10.1074/jbc.M115.675751. Epub 2015 Nov 3.

PMID:
26534959
11.

Can pictorial images communicate the quality of pain successfully?

Closs SJ, Knapp P, Morley S, Stones C.

Br J Pain. 2015 Aug;9(3):173-80. doi: 10.1177/2049463715569805.

12.

What do psychotherapists do? A systematic review and meta-regression of surveys.

Knapp P, Kieling C, Beck AT.

Psychother Psychosom. 2015;84(6):377-8. doi: 10.1159/000433555. Epub 2015 Sep 25. Review. No abstract available.

PMID:
26402554
13.

Oligodendrocytes Are Targets of HIV-1 Tat: NMDA and AMPA Receptor-Mediated Effects on Survival and Development.

Zou S, Fuss B, Fitting S, Hahn YK, Hauser KF, Knapp PE.

J Neurosci. 2015 Aug 12;35(32):11384-98. doi: 10.1523/JNEUROSCI.4740-14.2015.

14.

Effects of Testosterone Administration for 3 Years on Subclinical Atherosclerosis Progression in Older Men With Low or Low-Normal Testosterone Levels: A Randomized Clinical Trial.

Basaria S, Harman SM, Travison TG, Hodis H, Tsitouras P, Budoff M, Pencina KM, Vita J, Dzekov C, Mazer NA, Coviello AD, Knapp PE, Hally K, Pinjic E, Yan M, Storer TW, Bhasin S.

JAMA. 2015 Aug 11;314(6):570-81. doi: 10.1001/jama.2015.8881.

PMID:
26262795
15.

Changes in Side Effect Risk Communication in Patient Information Leaflets over the Past Decade: Results of a Survey.

Harris K, Dickinson R, Raynor DK, MacDonald J, Knapp P.

Drug Saf. 2015 Aug;38(8):721-7. doi: 10.1007/s40264-015-0307-7.

PMID:
26100144
16.

British-Pakistani women's perspectives of diabetes self-management: the role of identity.

Majeed-Ariss R, Jackson C, Knapp P, Cheater FM.

J Clin Nurs. 2015 Sep;24(17-18):2571-80. doi: 10.1111/jocn.12865. Epub 2015 Jun 22.

PMID:
26099049
17.

Opiate addiction therapies and HIV-1 Tat: interactive effects on glial [Ca²⁺]i, oxyradical and neuroinflammatory chemokine production and correlative neurotoxicity.

Fitting S, Zou S, El-Hage N, Suzuki M, Paris JJ, Schier CJ, Rodríguez JW, Rodriguez M, Knapp PE, Hauser KF.

Curr HIV Res. 2014;12(6):424-34.

18.

Chronic HIV-1 Tat and HIV reduce Rbfox3/NeuN: evidence for sex-related effects.

Hahn YK, Masvekar RR, Xu R, Hauser KF, Knapp PE.

Curr HIV Res. 2015;13(1):10-20.

19.

Sensitization of enteric neurons to morphine by HIV-1 Tat protein.

Fitting S, Ngwainmbi J, Kang M, Khan FA, Stevens DL, Dewey WL, Knapp PE, Hauser KF, Akbarali HI.

Neurogastroenterol Motil. 2015 Apr;27(4):468-80. doi: 10.1111/nmo.12514. Epub 2015 Feb 19.

20.

Combined verbal and numerical expressions increase perceived risk of medicine side-effects: a randomized controlled trial of EMA recommendations.

Knapp P, Gardner PH, Woolf E.

Health Expect. 2016 Apr;19(2):264-74. doi: 10.1111/hex.12344. Epub 2015 Jan 26.

PMID:
25645270
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk